Case Report: Autoimmune cerebellar ataxia with anti-neurochondrin antibodies following herpes simplex virus encephalitis: two cases and literature review
Background Autoimmune cerebellar ataxia (ACA) secondary to viral encephalitis is rarely reported. We describe two middle-aged male patients who developed primary autoimmune cerebellar ataxia (PACA) with serum- and cerebrospinal fluid (CSF)-positive anti-neurochondrin–eurochondrini-ne (NCDN-IgG) 5–8 weeks after recovery from herpesvirus encephalitis, alongside a systematic literature review. Methods We prospectively collected the clinical manifestations, laboratory findings, neuroimaging features, treatment regimens, and long-term follow-up data of the two enrolled patients. Metagenomic next-generation sequencing (mNGS) was performed on the CSF and peripheral blood for pathogen detection. Neural autoantibodies were screened using combined cell-based assay (CBA) and tissue-based assay (TBA). Results Both patients achieved full recovery from human herpesvirus 4 and human herpesvirus 6 encephalitis after standardized 3 weeks antiviral therapy. Following hospital discharge, both developed subacute pancerebellar syndromes manifesting as gait instability, dysarthria, and limb dysmetria. Brain magnetic resonance imaging demonstrated no cerebellar atrophy or focal parenchymal lesions. The serum and CSF NCDN-IgG were both positive at a titer of 1:100, whereas other cerebellitis-related autoantibodies were negative. Both patients received combined intravenous methylprednisolone pulse therapy plus intravenous immunoglobulin (IVIG), followed by tapering oral corticosteroids. Neurological function improved gradually, and both regained independent ambulation within 3 months. Whole-body 18 F-FDG PET-CT excluded underlying malignancy in both individuals. Conclusions Our observations showed a temporal association between the preceding herpesvirus family encephalitis and the subsequent anti-NCDN-mediated PACA, although causality cannot be established from this two-case series. Clinicians may consider NCDN-IgG testing for patients presenting with new-onset subacute cerebellar dysfunction after viral encephalitis, particularly when routine cerebellar autoantibody panels yield negative results. Early combined immunomodulatory therapy may facilitate neurological recovery. Larger prospective cohorts are required to validate our findings.
Authors
- 贾延劼
- Xinxin Wang (ORCID: https://orcid.org/0000-0002-7341-9780)
- Qinchen Cao
- Ruifang Wang
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3389/fimmu.2026.1954841
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00